Work

No evidence of disease versus residual disease in long-term responders to first-line HER2-targeted therapy for metastatic breast cancer

Year: 2021

Type: article

Study design: Observational Study

Source: British Journal of Cancer

DOI: 10.1038/s41416-021-01676-4

Authors: Zachary Veitch, Domen Ribnikar, Derek Tilley, Patricia A. Tang, Karen King, Philippe L. Bedard, Sasha Lupichuk, David W. Cescon

Institutions: St. Michael's Hospital, Princess Margaret Cancer Centre, Institute of Oncology Ljubljana, Alberta Health Services, Cancer Care Alberta, University of Alberta, Cross Cancer Institute

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4200511560

FWCI: 0.599

Cites: 38

Cited by: 13

Related to: 10